Martin A. Lehr - 19 Oct 2021 Form 3 Insider Report for Context Therapeutics Inc. (CNTX)

Role
Chief Executive Officer, Director
Signature
/s/ Tyler J. Vivian, Attorney-in-Fact
Issuer symbol
CNTX
Transactions as of
19 Oct 2021
Net transactions value
$0
Form type
3
Filing time
19 Oct 2021, 18:11:00 UTC
Next filing
17 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CNTX Common Stock 89,583 19 Oct 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CNTX Series A Preferred Stock 19 Oct 2021 Common Stock 210,722 Martin Lehr 2000 Trust F1, F2, F3
holding CNTX Series Seed Preferred Stock 19 Oct 2021 Common Stock 586,476 Martin Lehr 2000 Trust F1, F2, F3
holding CNTX Warrant (right to buy) 19 Oct 2021 Common Stock 52,680 $7.14 Martin Lehr 2000 Trust
holding CNTX Stock Option (right to buy) 19 Oct 2021 Common Stock 281,354 $4.94 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercisable upon the date of grant.
F2 N/A
F3 Converts to common stock on a one for one basis.
F4 The stock option vests each month (1/36 each month) from the date of the grant, April 30, 2021.